Search PDMR transactions

Notifier
Name
Erik Magnusson
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Erik Magnusson
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name
Promore Pharma AB
LEI
549300FJYXYRTU6R3M15
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Promore Pharma AB SE0009947740 Acquisition 4,044 Quantity 3.60 SEK 26/11/2020 NASDAQ STOCKHOLM AB
Share Promore Pharma AB SE0009947740 Acquisition 3,000 Quantity 3.66 SEK 26/11/2020 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Promore Pharma AB SE0009947740 Acquisition 26/11/2020 NASDAQ STOCKHOLM AB 7,044 (Quantity) 3.62555366 SEK
Total: 7,044
<< Back